These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23210283)

  • 21. Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients.
    Bester L; Meteling B; Pocock N; Pavlakis N; Chua TC; Saxena A; Morris DL
    J Vasc Interv Radiol; 2012 Jan; 23(1):96-105. PubMed ID: 22079516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The palliative role of 131I-MIBG and 111In-octreotide therapy in patients with metastatic progressive neuroendocrine neoplasms.
    Pasieka JL; McEwan AJ; Rorstad O
    Surgery; 2004 Dec; 136(6):1218-26. PubMed ID: 15657579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of therapy with [177Lu-DOTA0, Tyr3]octreotate in patients with paraganglioma, meningioma, small cell lung carcinoma, and melanoma.
    van Essen M; Krenning EP; Kooij PP; Bakker WH; Feelders RA; de Herder WW; Wolbers JG; Kwekkeboom DJ
    J Nucl Med; 2006 Oct; 47(10):1599-606. PubMed ID: 17015894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma.
    Welsh JS; Kennedy AS; Thomadsen B
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S62-73. PubMed ID: 16979443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Y90 selective internal radiation therapy and peptide receptor radionuclide therapy for the treatment of metastatic neuroendocrine tumors: combination or not?
    Yilmaz E; Engin MN; Özkan ZG; Kovan B; Büyükkaya F; Poyanli A; Sağlam S; Başaran M; Türkmen C
    Nucl Med Commun; 2020 Dec; 41(12):1242-1249. PubMed ID: 32941405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases.
    Cao CQ; Yan TD; Bester L; Liauw W; Morris DL
    Br J Surg; 2010 Apr; 97(4):537-43. PubMed ID: 20205229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival outcomes of a salvage patient population after radioembolization of hepatic metastases with yttrium-90 microspheres.
    Evans KA; Richardson MG; Pavlakis N; Morris DL; Liauw W; Bester L
    J Vasc Interv Radiol; 2010 Oct; 21(10):1521-6. PubMed ID: 20813542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioembolization with Yttrium-90 microspheres: review of an emerging treatment for liver tumors.
    Gates VL; Atassi B; Lewandowski RJ; Ryu RK; Sato KT; Nemcek AA; Omary R; Salem R
    Future Oncol; 2007 Feb; 3(1):73-81. PubMed ID: 17280504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential increased tumor-dose delivery with combined 131I-MIBG and 90Y-DOTATOC treatment in neuroendocrine tumors: a theoretic model.
    Madsen MT; Bushnell DL; Juweid ME; Menda Y; O'Dorisio MS; O'Dorisio T; Besse IM
    J Nucl Med; 2006 Apr; 47(4):660-7. PubMed ID: 16595501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors.
    Kennedy AS; McNeillie P; Dezarn WA; Nutting C; Sangro B; Wertman D; Garafalo M; Liu D; Coldwell D; Savin M; Jakobs T; Rose S; Warner R; Carter D; Sapareto S; Nag S; Gulec S; Calkins A; Gates VL; Salem R
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1494-500. PubMed ID: 19157721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioembolization in the treatment of unresectable liver tumors: experience across a range of primary cancers.
    Coldwell D; Sangro B; Salem R; Wasan H; Kennedy A
    Am J Clin Oncol; 2012 Apr; 35(2):167-77. PubMed ID: 21127414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization).
    Hoffmann RT; Paprottka P; Jakobs TF; Trumm CG; Reiser MF
    Abdom Imaging; 2011 Dec; 36(6):671-6. PubMed ID: 21584635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Radionuclide therapy of malignant tumors].
    Altenbrunn HJ
    Z Gesamte Inn Med; 1978 Jul; 33(14):475-84. PubMed ID: 581247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioembolization of liver tumors with yttrium-90 microspheres.
    Ahmadzadehfar H; Biersack HJ; Ezziddin S
    Semin Nucl Med; 2010 Mar; 40(2):105-21. PubMed ID: 20113679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective internal radiation therapy: 90Y (yttrium) labeled microspheres for liver malignancies (primary and metastatic).
    Uthappa MC; Ravikumar R; Gupta A
    Indian J Cancer; 2011; 48(1):18-23. PubMed ID: 21330750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspects on radionuclide therapy in malignant pheochromocytomas.
    Forssell-Aronsson E; Bernhardt P; Wängberg B; Kölby L; Nilsson O; Ahlman H
    Ann N Y Acad Sci; 2006 Aug; 1073():498-504. PubMed ID: 17102117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraarterial 131I-MIBG therapy of neuroendocrine tumors with liver metastases.
    Popp M; Strumpf A; Zöphel K; Stroszczynski C; Kotzerke J
    Nuklearmedizin; 2010; 49(1):N2-3. PubMed ID: 20336828
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer.
    Cao X; He N; Sun J; Tan J; Zhang C; Yang J; Lu T; Li J
    Chin Med J (Engl); 1999 May; 112(5):430-2. PubMed ID: 11593513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating radioembolization ((90)Y microspheres) into current treatment options for liver tumors: introduction to the international working group report.
    Kennedy A; Coldwell D; Sangro B; Wasan H; Salem R
    Am J Clin Oncol; 2012 Feb; 35(1):81-90. PubMed ID: 20938320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastric Ulcers Related to The Transarterial Radioembolization of Yittrium-90 in A Patient with Paraganglioma.
    Atay K; Akkoc FN; Samanci C; Gülsen F; Kepil N; Hatemi I
    Acta Gastroenterol Belg; 2017; 80(1):85-86. PubMed ID: 29364108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.